← Open Payments lookup

KEVIN WARE: Open Payments

NPI 1609817980 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$282,949 in 388 payments from 10 companies in 2025. Trend: 2023 $200,494 · 2024 $249,672 · 2025 $282,949

Speaker / faculty: $219,730Travel & lodging: $41,637Consulting: $14,220Food & beverage: $7,362
CompanyPaymentsAmount
Alkermes, Inc.216$160,499
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)145$114,257
Vanda Pharmaceuticals Inc.15$7,728
E.R. Squibb & Sons, L.L.C.5$228
Janssen Pharmaceuticals, Inc1$119
Teva Pharmaceuticals USA, Inc.2$37
Axsome Therapeutics, Inc.1$25
IDORSIA PHARMACEUTICALS US INC1$22
Gilead Sciences, Inc.1$20
Braeburn Inc.1$16

Products named: LYBALVI, CAPLYTA, ARISTADA, FANAPT, COBENFY, INVEGA SUSTENNA, Auvelity, Quviviq.

Industry payments across OH — which companies pay providers there.